Decision Support · Side-by-side
Compare pricing, strengths, and use cases so it is easier to pick the right fit.
Change tools
Neither ConcertAI nor IQVIA is for everyday users—they are enterprise-grade life sciences platforms. ConcertAI wins for deep oncology and regulatory-grade data, while IQVIA offers broader global commercial analytics. The single biggest difference is that ConcertAI focuses on oncology and imaging, whereas IQVIA covers the full drug lifecycle from trials to market.
ConcertAI
IQVIA
Scores at a glance
Choose ConcertAI if
Choose IQVIA if
Key differences
Facts side by side
| ConcertAI | IQVIA | |
|---|---|---|
| Free plan | ||
| Mobile app | ||
| API access |
Common questions
No. Neither tool has a mobile app. Both are designed for desktop use by trained professionals in enterprise settings.
Neither is a good fit. Both are expensive and complex. ConcertAI is slightly more specialized for oncology, but both require enterprise budgets and clinical expertise.
Pricing is not public for either, but ConcertAI is known to be extremely high and targeted at large pharma. IQVIA also charges enterprise rates. Neither is affordable for individuals or small teams.
Both support data integration (EHR, clinical data), but neither offers a public API or direct integrations with common business tools like Slack or Google Sheets. You will need IT support.
IQVIA is slightly easier because it offers training and dedicated account management. ConcertAI requires clinical research associates to be trained on its eurekaGraph interface—steep learning curve.
ConcertAI and IQVIA are powerful but expensive enterprise platforms for life sciences—neither is suitable for everyday users or small teams.
If you are an individual or small business, skip both—they are not for you. For large pharma companies, IQVIA is the more versatile choice for end-to-end drug development and commercial analytics, while ConcertAI is the specialist for oncology and imaging. Talk to their sales teams with a clear budget and use case in mind.
